Clustered Regularly Interspaced Palindromic Repeats-Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives
Summary
Filamentous fungi are important microbial cell factories for producing antibiotics, organic acids, enzymes, and other valuable products, with broad applications in food, agriculture, and medicine. However, inefficient and imprecise genome editing remains a major bottleneck limiting rational strain engineering. This review summarizes major genome-editing tools in filamentous fungi, including Cre-loxP, TALENs, and CRISPR-Cas systems, with emphasis on their mechanisms, advantages, and limitations.
Filamentous fungi are important microbial cell factories for producing antibiotics, organic acids, enzymes, and other valuable products, with broad applications in food, agriculture, and medicine. However, inefficient and imprecise genome editing remains a major bottleneck limiting rational strain engineering. This review summarizes major genome-editing tools in filamentous fungi, including Cre-loxP, TALENs, and CRISPR-Cas systems, with emphasis on their mechanisms, advantages, and limitations. We highlight CRISPR-Cas9 as the predominant platform and discuss optimization strategies involving sgRNA design, engineered Cas9 variants, promoter engineering, AMA1-based replicative plasmids, and ribonucleoprotein delivery. Emerging technologies, including base editing, prime editing, Cas12a, and Mad7, are also discussed for their potential to broaden editing capabilities. Finally, we outline future perspectives focusing on extending the application of existing genome-editing systems in filamentous fungi and discovering novel genome-editing tools from large-scale omics data sets. This review will accelerate the development of filamentous fungi as versatile platforms for biomanufacturing.
Abstract from PubMed (PMID 43012712). This entry was added automatically by our daily literature monitor because it matches the topics we follow; read the full paper at the original source.
Related articles
CRISPR, mRNA, and Beyond: Nucleic Acid Therapeutics in Allergy and Immunology
MedCommCRISPR Technology: From Bench to Bedside Applications
Advanced healthcare materialsEngineered Milk-Derived Extracellular Vesicles Integrate PCSK9 Silencing and Inflammation Modulation for Hyperlipidemia Therapy
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.
